London, United Kingdom

Norman Miller

This inventor holds 1 USPTO granted patent. Top assignee: Zlb Behring Ag. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norman Miller. Retrieved from https://idiyas.com/inventor/norman-miller-zhcg3vg9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Medical Science: The Contributions of Inventor Norman Miller

Introduction: Norman Miller, a prominent inventor based in London, GB, has made significant strides in the field of medical science. With his groundbreaking patent, he is contributing to the prevention and treatment of organ dysfunction, which is crucial in emergency medical situations.

Latest Patents: Miller holds a patent for "High density lipoprotein against organ dysfunction following haemorrhagic shock." This patent focuses on the use of high density lipoprotein (HDL) and its derivatives in manufacturing a medicament aimed at preventing or treating organ dysfunction after ischaemia and reperfusion injury. The implications of this invention are particularly relevant for patients with end-stage organ injury or failure, providing new avenues for medical interventions in critical care.

Career Highlights: Currently employed at ZLB Behring AG, Norman Miller has positioned himself at the forefront of innovative medical solutions. His dedication to advancing healthcare, coupled with his expertise, has allowed him to develop impactful medications that can significantly improve patient outcomes in dire situations.

Collaborations: In his professional journey, Miller has collaborated with notable colleagues, including Gillian Cockerill and Christoph Thiemermann. These collaborations underscore the importance of teamwork in driving medical research and innovation, combining their knowledge to push the boundaries of what is possible in treatment methodologies.

Conclusion: Norman Miller represents a beacon of hope in medical innovation. With his patent addressing critical organ dysfunction following traumatic medical incidents, he is paving the way for more effective treatments and ultimately improving the quality of care for patients in need. His work at ZLB Behring AG and collaborations with esteemed professionals further amplify the impact of his contributions in the healthcare sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…